Publications by authors named "Alyssa Cull"

Claim this Profile
L
Low-input proteomics identifies vWF as a negative regulator of Tet2 mutant hematopoietic stem cell expansion.
Maria Jassinskaja, Daniel Bode, Monika Gonka, Theodoros I Roumeliotis, Alexander J Hogg, Alyssa H Cull

Cell Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Of donors and dynamics.
Alyssa H Cull, David G Kent

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disorders.
Alyssa H Cull, David G Kent, Alan J Warren

Blood· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models.
Miriam Belmonte, Lilia Cabrera-Cosme, Nina F Øbro, Juan Li, Jacob Grinfeld, Alyssa H Cull

Exp Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.
Michael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, Erica B Esrick, Emily Mitchell

Nat Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim.
Adam Al-Hakim, Alyssa Cull, Joanna Topping, Fatima Nadat, Joanna Milek

Hemasphere· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of in vitro expanded hematopoietic stem cells.
James L C Che, Daniel Bode, Iwo Kucinski, Alyssa H Cull, Fiona Bain

EMBO Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse mutational landscapes in human lymphocytes.
Heather E Machado, Emily Mitchell, Nina F Øbro, Kirsten Kübler, Megan Davies, Alyssa Cull

Nature· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting Single-Cell Tools in Gene and Cell Therapy.
Daniel Bode, Alyssa H Cull, Juan A Rubio-Lara, David G Kent

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tet2 restrains inflammatory gene expression in macrophages.
Alyssa H Cull, Brooke Snetsinger, Rena Buckstein, Richard A Wells, Michael J Rauh

Exp Hematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.
Mikkael A Sekeres, Megan Othus, Alan F List, Olatoyosi Odenike, Richard M Stone, Alyssa H Cull

J Clin Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes.
Alyssa H Cull, Michael J Rauh

J Leukoc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis